- Release Date: 13/10/17 08:59
- Summary: Neuren FDA meeting confirms Phase 3 plan for Rett syndrome
- Price Sensitive: Yes
- Download Document 102.03KB
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren FDA meeting confirms Phase 3 plan for Rett syndrome
Ann: Neuren FDA meeting confirms Phase 3 plan for Rett syndrome
-
- There are more pages in this discussion • 138 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$14.07 |
Change
-0.400(2.76%) |
Mkt cap ! $1.798B |
Open | High | Low | Value | Volume |
$14.47 | $14.53 | $13.99 | $7.843M | 552.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 2150 | $14.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.10 | 1129 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2150 | 14.060 |
1 | 49 | 14.040 |
2 | 5301 | 14.010 |
6 | 5183 | 14.000 |
2 | 2328 | 13.990 |
Price($) | Vol. | No. |
---|---|---|
14.100 | 1129 | 2 |
14.120 | 493 | 1 |
14.140 | 1566 | 2 |
14.150 | 4156 | 2 |
14.170 | 600 | 1 |
Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |